How much funding has NEXTRAST, INC raised?

NEXTRAST, INC has raised $822K in total funding, most recently a Grant round.

When was NEXTRAST, INC founded?

NEXTRAST, INC was founded in 2015.

Where is NEXTRAST, INC headquartered?

NEXTRAST, INC is headquartered in BURLINGAME, California, United States.

What industry is NEXTRAST, INC in?

NEXTRAST, INC operates in Biotech, Healthcare.

How many employees does NEXTRAST, INC have?

NEXTRAST, INC has 1-10 employees.

NEXTRAST, INC

Novel CT contrast agents for unprecedented imaging clarity

BURLINGAME, United States · Founded 2015 · $822K raised

Biotech

Healthcare

Headquarters: BURLINGAME, California
Employees: 1–10
Founded: 2015
Business Model: B2B

Website: nextrast.com
Total Funding: $822K
Last Round: $822K GrantJan 2021

About

Nextrast is a clinical-stage medical imaging company developing novel CT contrast agents to dramatically improve imaging capabilities. Its oral agent darkens the bowel lumen for superior anatomic delineation in oncology staging and inflammatory bowel disease, while its intravenous blood-pool agent enables prolonged vascular imaging for cardiovascular and liver applications. The company has completed Phase 2 clinical trials demonstrating detection of previously impossible-to-find bowel tumors.

Summary

NEXTRAST, INC is a Biotech company based in BURLINGAME, United States, founded in 2015. It has raised $822K in total, most recently a $822K Grant round in Jan 2021.